Keyßer G
Department für Innere Medizin, Klinik für Innere Medizin II, Universitätsklinikum Halle, Ernst-Grube-Str. 40, 06097, Halle (Saale), Deutschland.
Z Rheumatol. 2012 Aug;71(6):468-72. doi: 10.1007/s00393-011-0878-3.
Conventional disease-modifying antirheumatic drugs (DMARDs) were formerly introduced into the treatment of rheumatoid arthritis and other rheumatic disorders on an empirical basis. In many cases their mode of action is only partially understood but as a rule of thumb they act on more than one point within the cellular metabolism. Less often they exert biological effects in the extracellular space or on the cell membrane.
传统的改善病情抗风湿药(DMARDs)以前是在经验基础上被引入类风湿关节炎和其他风湿性疾病的治疗。在许多情况下,它们的作用方式仅被部分理解,但一般来说,它们作用于细胞代谢中的多个点。它们在细胞外空间或细胞膜上发挥生物学效应的情况较少见。